Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Encouraging phase III results reported for lamivudine as hepatitis B treatment

April 11, 1997

Taisho/Ikeda Mohando describe anti-H. pylori agent

April 9, 1997

Fujisawa reports antiulcer agents

April 9, 1997

5-LO inhibitor not effective as monotherapy in active ulcerative colitis

April 7, 1997

Positive phase III results reported for Centocor's Crohn's disease treatment

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Transdermal nicotine associated with clinical improvement in ulcerative colitis

April 2, 1997

Gilead's GS-840 enters phase II for chronic hepatitis B treatment

April 1, 1997

Extended treatment with Intron A for hepatitis C cleared by FDA

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...